DIG
NVNO

Dauntless Investment Group’s enVVeno Medical NVNO Stock Holding History

Dauntless Investment Group’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,024
Closed -$186K – 83
2025
Q1 		$186K Buy
+2,024
New +$226K 0.22% 50

Other funds holding NVNO

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $58.1B AUM 27.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dauntless Investment Group's NVNO Position: Q2 2025 in Review

Dauntless Investment Group sold out of enVVeno Medical (NVNO) in Q2 2025, closing a stake of 2,024 shares — an estimated $186K sold.

Dauntless Investment Group first reported a position in NVNO in Q1 2025 and held it in 1 quarter. The position peaked at $186K in Q1 2025. 37 funds tracked by Wall St. Rank hold NVNO as of Q2 2025.

  • Dauntless Investment Group reported no remaining enVVeno Medical position as of Q2 2025 after selling out during the quarter.
  • Dauntless Investment Group sold 2,024 enVVeno Medical shares in Q2 2025, an estimated $186K.
  • Dauntless Investment Group first reported a position in enVVeno Medical in Q1 2025 and held it in 1 quarter.
  • Dauntless Investment Group's enVVeno Medical position peaked at $186K in Q1 2025.
  • 37 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2025.

Based on Dauntless Investment Group's 13F filing for Q2 2025, filed 14 Aug 2025.